Logo

American Heart Association

  32
  0


Final ID:

Silent Killer 2- Subclinical ASCVD

  • Savage, Michael  ( Michael Savage , Philadelphia , Pennsylvania , United States )
  • Al-kindi, Sadeer  ( Houston Methodist , Houston , Texas , United States )
  • Blaha, Michael  ( JOHNS HOPKINS HOSPITAL , Baltimore , Maryland , United States )
  • Author Disclosures:
    Michael Savage: DO NOT have relevant financial relationships | Sadeer Al-Kindi: DO have relevant financial relationships ; Research Funding (PI or named investigator):Ionis Pharmaceuticals:Active (exists now) | Michael Blaha: DO have relevant financial relationships ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) ; Consultant:Eli Lilly:Past (completed) ; Consultant:Boehringer Ingelheim:Past (completed) ; Consultant:Astra Zeneca:Past (completed) ; Consultant:New Amsterdam:Active (exists now) ; Consultant:Agepha:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Idorsia:Past (completed) ; Consultant:Genentech:Past (completed) ; Consultant:Bayer:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Research Funding (PI or named investigator):Bayer:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Pecha Kucha Says: It’s All About Managing Cardiovascular-Kidney-Metabolic Health

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Getting to the Heart of Prevention in Children

Baker-smith Carissa, Batra Anjan, Perak Amanda

The Intersection of Liver and CKM Syndrome

Pandey Ambarish, Sanyal Arun, Mehta Anurag, Mamas Mamas, Rajapreyar Indranee

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available